---
title: Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia
date: '2024-07-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39078289/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240730181427&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSIONS: Our findings suggest that tailoring induction regimens
  using ACS10 scores can significantly improve outcome in patients with AML. Given
  the SNPs are germline, preemptive genotyping can accelerate matching the most effective
  remission induction ...'
disable_comments: true
---
CONCLUSIONS: Our findings suggest that tailoring induction regimens using ACS10 scores can significantly improve outcome in patients with AML. Given the SNPs are germline, preemptive genotyping can accelerate matching the most effective remission induction ...